Animal Models Core
Animal Models Core
批准号:
10306366
负责人:
Venetia Zachariou
金额:
$35.83万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-02-15 至 2023-11-30
关键词:
Advisory CommitteesAlgorithmsAnimal ModelAnimalsBehaviorBehavioralBehavioral AssayBiological AssayBlood Chemical AnalysisBlood drug level resultBrainBrain regionCell physiologyCellsChromatinCognitiveCollaborationsCommittee MembersComplexContinuous InfusionCorticosteroneDataDissectionDominant-Negative MutationDrug AddictionEnsureFemaleFiberGene TransferGenesGeneticGenetic TranscriptionGoalsHeroinHumanImageIndividualInjectionsKnock-outLinkMeasurementMeasuresMediatingMicrodissectionModelingMolecularMotivationMusMutant Strains MiceNational Institute of Drug AbuseNeurogliaNeuronsNeurosecretory SystemsOpiate AddictionOpioidPharmaceutical PreparationsPhotometryPlasmaProceduresProcessProgram Research Project GrantsProteinsRNARattusRelapseResearch PersonnelResourcesRodentRodent ModelRoleRunningSelf AdministrationServicesSpecificityStimulantStressSyndromeTestingViral VectorWorkaddictionbehavior testbrain reward regionsbrain tissuecell typechromatin modificationcocaine self-administrationcohortdrug actiondrug cravingdrug relapseexperimental studygene functiongenome-wideheroin usein vivoinhibitorinjection/infusioninterestmalemature animalmeetingsmutantneural circuitneurophysiologynoveloptogeneticsosmotic minipumpoverexpressionsmall hairpin RNAstatisticsstimulant dependencetool
中文摘要
项目总结/摘要-动物模型核心
动物模型核心的一个主要目标是提供一个广泛的行为分析的兴奋剂
和阿片作用,以支持PPG的总体目标,即建立分子和细胞
成瘾的基础。这些分析包括几个常规的行为测试以及更复杂的自我测试。
给药和复发程序。采用广泛的行为电池是至关重要的,因为很难
从一个单一的模型甚至是有限的模型中推断出一些复杂的行为综合症,比如成瘾,
模型的数量。核心以两种主要方式利用这些行为资源。第一,核心
提供了啮齿动物大脑奖励区域的显微解剖,这些啮齿动物自我服用可卡因或海洛因,
每个项目中的分子细胞表征以及基因和染色质分析核心。二是
核心与四个项目中的每一个项目合作,以产生直接联系特定分子和
细胞对特定行为异常的适应,这些行为异常定义了成瘾状态。核心
通过提供一系列遗传突变小鼠以及大量载体来实现这一目标,
病毒介导的基因转移,所有这些都得到了核心的广泛验证。突变小鼠和病毒
矢量,通常最初是为了满足单个项目的特定需求而生成的,然后提供给其他项目。
扩大其应用范围并从而促进PPG集成的项目。PPG调查人员领导了
在产生突变小鼠和病毒载体领域,这使得有可能选择性地操纵给定的基因
在成年动物的特定细胞类型和大脑区域内的感兴趣的细胞,从而避免与更多的细胞混淆。
传统的方法。最后,核心提供先进的神经生理学,光遗传学和纤维
测光工具,项目调查人员直接涉及改变分子细胞功能成瘾-
相关的行为异常通过巩固这一行为,小鼠突变,病毒载体,和其他工作
在一个集中的核心,我们确保严格控制数据,并促进比较和对比,
在各个项目的实验结果。这种整合也具有财务意义,因为我们
集中并最大限度地有效利用所需的专门知识。
英文摘要
PROJECT SUMMARY/ABSTRACT– ANIMAL MODELS CORE
A main objective of the Animal Models Core is to provide a broad range of behavioral assays of stimulant
and opiate action in mice and rats to support the PPG’s overall goal to establish the molecular and cellular
basis of addiction. Such assays include several routine behavioral tests as well as more sophisticated self-
administration and relapse procedures. It is crucial to employ a broad behavioral battery since it is difficult to
infer something about a complex behavioral syndrome like addiction from a single model or even a limited
number of models. The Core then utilizes these behavioral resources in two main ways. First, the Core
provides microdissections of brain reward regions from rodents that self-administer cocaine or heroin for
molecular-cellular characterization in each Project and the Gene and Chromatin Analysis Core. Second, the
Core works with each of the four Projects to generate causal evidence that directly links specific molecular and
cellular adaptations to particular behavioral abnormalities that define a state of addiction. The Core
accomplishes this goal by providing a range of genetic mutant mice as well as a large number of vectors for
viral-mediated gene transfer, all of which are extensively validated by the Core. The mutant mice and viral
vectors, often generated initially to meet the specific needs of an individual Project, are then provided to other
Projects to broaden their application and thereby promote PPG integration. PPG investigators have led the
field in generating mutant mice and viral vectors, which make it possible to selectively manipulate a given gene
of interest within a particular cell type and brain region of adult animals, thus avoiding confounds with more
traditional approaches. Finally, the Core provides advanced neurophysiology, optogenetic, and fiber
photometry tools to Project investigators to directly relate altered molecular-cellular function to addiction-
related behavioral abnormalities. By consolidating this behavioral, mouse mutant, viral vector, and other work
within a centralized Core, we ensure rigorous control over the data and facilitate comparisons and contrasts of
experimental results across the individual Projects. This consolidation also makes financial sense, since we
concentrate and maximize efficient use of the required expertise.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular Mechanisms of Antidepressant Drug Actions in Neuropathic Pain Models
-
批准号:10830180
-
项目类别:
-
资助金额:$36.34万
-
财政年份:2023
-
负责人:Venetia Zachariou
-
依托单位:
Cellular mechanisms of antidepressant drug actions in neuropathic pain models
-
批准号:10526787
-
项目类别:
-
资助金额:$7.52万
-
财政年份:2022
-
负责人:Venetia Zachariou
-
依托单位:
Cellular mechanisms of antidepressant drug actions in neuropathic pain models
-
批准号:10303381
-
项目类别:
-
资助金额:$3.21万
-
财政年份:2021
-
负责人:Venetia Zachariou
-
依托单位:
A Female Specific Role of RGSz1 in Modulation of Chronic Pain
-
批准号:10441146
-
项目类别:
-
资助金额:$36.53万
-
财政年份:2020
-
负责人:Venetia Zachariou
-
依托单位:
A Female Specific Role of RGSz1 in Modulation of Chronic Pain
-
批准号:10834544
-
项目类别:
-
资助金额:$17.51万
-
财政年份:2020
-
负责人:Venetia Zachariou
-
依托单位:
A Female Specific Role of RGSz1 in Modulation of Chronic Pain
-
批准号:9981335
-
项目类别:
-
资助金额:$43.26万
-
财政年份:2020
-
负责人:Venetia Zachariou
-
依托单位:
Cellular Mechanisms of Antidepressant Drug Actions in Neuropathic Pain Models
-
批准号:10434903
-
项目类别:
-
资助金额:$41.33万
-
财政年份:2019
-
负责人:Venetia Zachariou
-
依托单位:
Cellular mechanisms of antidepressant drug actions in neuropathic pain models
-
批准号:10542571
-
项目类别:
-
资助金额:$12.05万
-
财政年份:2019
-
负责人:Venetia Zachariou
-
依托单位:
Animal Models Core
-
批准号:10062502
-
项目类别:
-
资助金额:$33.23万
-
财政年份:2019
-
负责人:Venetia Zachariou
-
依托单位:
Cellular mechanisms of antidepressant drug actions in neuropathic pain models
-
批准号:10532060
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2019
-
负责人:Venetia Zachariou
-
依托单位:
Animal Models Core
-
批准号:10533286
-
项目类别:
-
资助金额:$35.83万
-
财政年份:2019
-
负责人:Venetia Zachariou
-
依托单位:
Targeting HDAC6 for the treatment of neuropathic pain
-
批准号:9387865
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2017
-
负责人:Venetia Zachariou
-
依托单位:
Cellular Mechanisms of Antidepressant Drug Actions in Neuropathic Pain Models
-
批准号:9314647
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2014
-
负责人:Venetia Zachariou
-
依托单位:
Cellular Mechanisms of Antidepressant Drug Actions in Neuropathic Pain Models
-
批准号:8761587
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2014
-
负责人:Venetia Zachariou
-
依托单位:
Cellular Mechanisms of Antidepressant Drug Actions in Neuropathic Pain Models
-
批准号:9116307
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2014
-
负责人:Venetia Zachariou
-
依托单位:
海外基金